Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.
Ann Oncol
; 32(10): 1256-1266, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34384882
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Female
/
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Country of publication:
Reino Unido